We use a non-malignant breast cell line (MCF10A), a less aggressive luminal A breast cancer cell line (MCF7) and aggressive breast cancer cell lines MDA231 (also known as MDA-MB-231) which is triple-negative and the HER2+ cell line (SKBR3). The gene discussed is ERBB2; the disease is breast carcinoma.